Skip navigation

Search results for the care act 2014

Showing 166 to 180 of 401 results

One week until the HCPC updated standards of proficiency come into effect

There's just one week until 1 September 2023, when the updated HCPC standards of proficiency come into effect. We encourage all registrants to ensure they understand the updates and are ready to integrate them as far as they relate to their scope of practice. 

Using AI at HCPC

It’s always exciting when new technologies arrive that can save us time and have the potential to help us to achieve new things. But it’s important we are mindful of the risks when adopting any new technology.

Our requirements of programmes meeting the revised standards of education and training

Last summer, we asked all pre-registration programmes to plan how they would meet the revised standards of education and training (SETs). From the 2018–19 academic year, we will assess whether your programme has met these standards via our annual monitoring process.

New Executive Director of Regulation

HCPC is delighted to announce the appointment of Andrew Smith as their new Executive Director of Regulation.

HCPC fee rise: Fee increase approved

The increase has now passed through both parliaments and will come into force as law in July.

HCPC joins healthcare regulators to publish latest whistleblowing report

The HCPC, in collaboration with seven other professional healthcare regulators, has published an annual report on whistleblowing disclosures.

Chiropodist, podiatrist and hearing aid dispenser renewals - window closing soon

The deadline for chiropodists, podiatrists and hearing aid dispensers to complete their registration renewal is fast approaching

Launch of consultation for the standards of conduct, performance and ethics

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

Joint statement on meeting regulatory standards during periods of global or national shortage of medicines

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

Top